Cellular Goods PLC Cellular Goods boosts team with five appointments
April 12 2021 - 2:00AM
RNS Non-Regulatory
TIDMCBX
Cellular Goods PLC
12 April 2021
12 April 2021
Cellular Goods PLC
("Cellular Goods" or "the Company")
Cellular Goods strengthens team with five new appointments
Cellular Goods (LSE: CBX), a UK-based provider of premium
consumer products based on biosynthetic cannabinoids, is pleased to
announce that it has appointed a new Head of Process and Applied
Sciences, made two senior hires to its product development team and
contracted two expert consultants to advise on the development of
the Company's pet care and skincare ranges .
Istok Nahtigal joins as Head of Process and Applied Sciences to
focus on Cellular Goods' cannabinoid supply chain and will be
responsible for optimising the Company's relationships with its
manufacturing partners. Istok is a Chartered Chemist and cannabis
industry expert in the field of fermentation and bio-extractions.
He has an impressive track record and his work has led to multiple
inventions and patents in cannabinoid purification. Previously,
Istok was a key scientific member of LAVVAN, a pioneering company
focused on commercialising high-quality cannabinoid ingredients
using synthetic biology, and MedReleaf Corp, one of the first
Canadian producers of medical cannabis to receive a license from
Health Canada. Prior to this, he held the role of Process Scientist
at Bionche Life Sciences, leading the group evolving novel
fermentation and downstream purification schemes for an E.coli
vaccine.
Amanda Pape and Melissa Santolini join the product development
team as Senior Quality Assurance Manager and Lead Project Manager
respectively and will support Cellular Goods' product development,
quality assurance, and roll out. Amanda is a healthcare
professional with over 15 years of experience working in hospital
diagnostic laboratories who has transferred her expertise to the
cannabis industry. In 2020 Amanda founded her own quality assurance
consulting company, working collaboratively with cannabis licensed
providers to implement regulatory requirements and Quality
Management Systems. Prior to this, she was also the Quality
Assurance Manager at LAVVAN. Melissa has experience in the
cannabis, pharmaceutical and agrochemical sectors. She was most
recently at LAVVAN, where she focused on driving regulatory,
product development and quality initiatives. Prior to LAVVAN,
Melissa led product chemistry projects as a chemist at UPL Ltd, a
global provider of crop protection chemicals, and held an
analytical R&D role at Apotex Pharmachem Inc, a division of the
Apotex group of companies.
Caroline Queen has been appointed as Pet Care Advisor and will
provide consultancy regarding the development of Cellular's pet
care range. This will include identifying suitable applications for
cannabinoids in pet products and meeting associated regulatory and
veterinary requirements. Caroline has an extensive background in
the clinical and veterinary industry. She was formerly the Senior
Business Development Director at Vet Partners Ltd, a veterinary
group providing centralised support to individual practices across
the UK.
Antony Buck has been appointed as Skincare Business Adviser and
will be providing consultancy regarding the development of the
Company's skincare range which will launch this year. In 2000
Antony created REN Skincare, a multi-award-winning brand that is
sold in 50 countries and has a committed consumer base, with its
range being sold predominantly in specialty stores and pharmacies.
Antony successfully grew REN into a global brand with annual
turnover excess of GBP40m before selling the business to Unilever
in 2015.
Alexis Abraham, Chief Executive of Cellular Goods, commented:
"Cellular Goods is executing on our differentiated business
strategy: one focused on delivering clarity and consistent quality
for consumers and leading the fast-moving consumer goods
cannabinoid market through science and brand expertise. I am very
pleased to welcome Istok, Caroline, Amanda, Melissa, and Antony. In
their respective areas they complement our world-class team and
will be a huge asset as we continue product development and gear up
to releasing the first items in our skincare line this autumn."
Cellular Goods
Alexis Abraham +44 207 031 6871
Chief Executive
Neil Thapar
Investor Relations +44 787 645 5323
------------------
Tennyson Securities
------------------
Corporate Broker
Peter Krens +44 207 186 9030
------------------
Novum Securities
------------------
Corporate Broker
Colin Rowbury
Jon Belliss +44 207 399 9427
------------------
Tancredi Intelligent Communication
Media Relations
------------------
Helen Humphrey
Edward Daly +44 744 922 6720
Salamander Davoudi +44 786 143 0057
cellulargoods@tancredigroup.com +44 795 754 9906
------------------
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAGZGMDMMKGMZZ
(END) Dow Jones Newswires
April 12, 2021 02:00 ET (06:00 GMT)
Cellular Goods (LSE:CBX)
Historical Stock Chart
From Apr 2024 to May 2024
Cellular Goods (LSE:CBX)
Historical Stock Chart
From May 2023 to May 2024